Work

Evaluation of Hexadecyloxypropyl-9- R -[2-(Phosphonomethoxy)Propyl]-Adenine, CMX157, as a Potential Treatment for Human Immunodeficiency Virus Type 1 and Hepatitis B Virus Infections

Year: 2007

Type: article

Source: Antimicrobial Agents and Chemotherapy

DOI: 10.1128/aac.01375-07

Authors: George R. Painter, Merrick R. Almond, Lawrence C. Trost, Bernhard M. Lampert, Johan Neyts, Erik De Clercq, Brent E. Korba, Kathy A. Aldern, James R. Beadle, Karl Y. Hostetler

Institutions: Rega Institute for Medical Research, Georgetown University Medical Center, University of California San Diego, Chimerix (United States), KU Leuven

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4249196604

FWCI:

Cites:

Cited by: 4

Related to: 10